Why Accelerate Diagnostics Shares Are Trading Higher Today
Becton Dickinson and Co (NYSE:BDX) will sell Accelerate Diagnostics Inc’s (NASDAQ:AXDX) rapid testing solution for antibiotic resistance and susceptibility, offering results in…
Boston Scientific Adds ‘Novel’ Technology Via This Acquisition For Interventional Oncology
Boston Scientific Corporation (NYSE:BSX) has acquired privately-held Obsidio Inc that developed the Gel Embolic Material (GEM) technology to embolize blood vessels in the…
Weekend Stock Spotlight: Affirm, SoftBank And How Trump Documents Seizure May Impact Midterms
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read.
3 Dividend Plays To Watch in Semiconductors With The CHIPS Act As Law of The Land
President Joe Biden recently signed the $280 billion dollar CHIPS and Science Act, setting aside roughly $52 billion dollars to bolster the U.S. computer chip sector.
After supply chain shortages and record demand for semiconductors, the CHIPS act will boost the domestic semiconductor manufacturing industry to better compete with China.
Bulls and Bears Of The Week: NVIDIA, Tesla, GameStop, AMC, And Why Disney Could Run 40% Higher
Benzinga has examined the prospects for many investors' favorite stocks over the past week, here's a look at some of our top stories.
Competitor Recall Continues To Show Opportunities For ResMed
ResMed Inc (NYSE:RMD) posted Q4 sales of $914.7 million, +4% Y/Y (+8% on a constant currency basis), beating the consensus…
Don’t Treadmill On Me: Peloton Chops 750 Jobs, Boosts Prices, Closes Stores As Reorganization Picks Up Steam
On Friday, Peloton Interactives Inc. (NASDAQ: PTON) told its employees the company will be slashing roughly 780 jobs and will be closing a significant number of its retail stores.
Senate Finance Committee Expands Amgen’s Tax Probe: Report
Senator Ron Wyden sent a letter to Amgen Inc (NASDAQ: AMGN) asking what methods the company has used to pay an average effective tax rate of around 12% over the past four years.
FDA Approves Expanded Use Of Roche’s Influenza Treatment
The FDA has approved the expanded use of Roche Holding AG’s (OTC:RHHBY) Xofluza (baloxavir marboxil). The medicine has been approved to treat…
Daiichi-AstraZeneca’s Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
The FDA has approved Daiichi Sankyo (OTC:DSNKY) and AstraZeneca plc’s (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic non-small cell lung cancer (NSCLC)…